# Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

> **NCT01720069** · PHASE2,PHASE3 · COMPLETED · sponsor: **Vectura Limited** · enrollment: 197 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** VR506

## Key facts

- **NCT ID:** NCT01720069
- **Lead sponsor:** Vectura Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720069, "Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01720069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*